首页> 美国卫生研究院文献>BMC Health Services Research >Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

【2h】

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

机译：耐多药结核病诊断和治疗启动的途径：快速分子诊断测试时代患者经验的定性比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAlthough new molecular diagnostic tests such as GenoType MTBDRplus and Xpert® MTB/RIF have reduced multidrug-resistant tuberculosis (MDR-TB) treatment initiation times, patients’ experiences of diagnosis and treatment initiation are not known. This study aimed to explore and compare MDR-TB patients’ experiences of their diagnostic and treatment initiation pathway in GenoType MTBDRplus and Xpert® MTB/RIF-based diagnostic algorithms.

机译：背景技术尽管新的分子诊断测试（例如GenoType MTBDRplus和Xpert®MTB / RIF）减少了耐多药结核病（MDR-TB）的治疗起始时间，但患者的诊断和治疗起始经验尚不清楚。这项研究旨在探讨和比较基于GenoType MTBDRplus和Xpert®MTB / RIF的诊断算法中耐多药结核病患者的诊断和治疗起始途径的经验。

著录项

期刊名称 BMC Health Services Research
作者
Pren Naidoo; Margaret van Niekerk; Elizabeth du Toit; Nulda Beyers; Natalie Leon;
展开▼
作者单位

展开▼
年(卷),期 2015(15),-1
年度 2015
页码 488
总页数 13
原文格式 PDF
正文语种
中图分类医院、综合医院;中医院;
关键词
GenoType MTBDRplus line probe assay Xpert® MTB/RIF Pathways to care Health-seeking behaviour Diagnostic and treatment delay Obstacles to care;

机译：GenoType MTBDRplus线探针测定;Xpert®MTB / RIF;护理途径;健康追求行为;诊断和治疗延迟;护理障碍;

相似文献

外文文献
中文文献
专利

1. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests [J] . Pren Naidoo, Margaret van Niekerk, Elizabeth du Toit, BMC Health Services Research . 2015,第1期

机译：多药结核病诊断和治疗开始的途径：患者在快速分子诊断测试时代的患者经验的定性比较
2. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant TB, Tamil Nadu, India [J] . Nair Dina, Navneethapandian Pooranaganga D., Tripathy Jaya Prasad, Transactions of the Royal Society of Tropical Medicine and Hygiene . 2016,第9期

机译：快速分子诊断测试对耐多药结核病患者开始治疗和治疗结果的时间的影响，印度泰米尔纳德邦
3. Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California [J] . Ritu Banerjee, Jennifer Allen, S.-Y. Grace Lin, Journal of Clinical Microbiology . 2010,第10期

机译：快速的药敏试验与分子信标测定法与早期诊断和治疗在加利福尼亚州的耐多药结核病有关
4. The Complex Treatment with Mellozan Immunomodulator of Patients with Multidrug-Resistant Tuberculosis [C] . Sain D., Cula E., Nepoliuc L., World Asthma and COPD Forum . 2010

机译：多药抗性结核病患者Mellozan免疫调节器的复杂处理
5. The Effectiveness of Home Based Management of Uncomplicated Malaria Using Artemisinin Combination Treatments (ACTs) and Rapid Diagnostic Tests (RDTs) in Rural Senegal (West Africa): Pilot Study in Three Districts. [D] . Seck, Ibrahima. 2017

机译：塞内加尔农村地区（西非）使用青蒿素联合治疗（ACT）和快速诊断测试（RDT）对家庭进行简单疟疾管理的有效性：三个地区的初步研究。
6. Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California [O] . Ritu Banerjee, Jennifer Allen, S.-Y. Grace Lin, 2010

机译：快速的药物敏感性检测与分子信标测定与早期诊断和治疗在加利福尼亚州的耐多药结核病有关
7. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests [O] . Pren Naidoo, Margaret van Niekerk, Elizabeth du Toit, 2015

机译：耐多药结核病诊断和治疗启动的途径：快速分子诊断测试时代患者经验的定性比较

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

摘要

著录项

相似文献

相关主题

期刊订阅